One study showed that the pharmacological inhibition of PP2A could confer resistance to treatment with the inhibitors of cutaneous squamous cell carcinoma cell proliferation, whereas the overexpression of wild-type PP2A led to the opposite results [36]. This evidence concerns the gene PTPA and cutaneous squamous cell carcinoma.